THCBFOTCHealthcare · Drug Manufacturers - Specialty & Generic

THC Biomed Intl Ltd.

$0.00+0.00%(+$0.00)

TickerSpark Score

47/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a THCBF research report →

52-Week Range0% of range

Low $0.00

Current $0.00

High $0.02

Companythcbiomed.com

THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks.

CEO: John Miller
IPO: 2018
Employees: 35
HQ: Kelowna, BC, CA

Price Chart

-99.90% · this period

Valuation

Market Cap: $205.01K
P/E: -1.07
P/S: 0.98
P/B: 0.47
EV/EBITDA: -4.45
Div Yield: 0.00%

Profitability

Gross Margin: -30.83%
Op Margin: -95.89%
Net Margin: -91.79%
ROE: -36.68%
ROIC: -28.04%

Growth & Income

Revenue: $2.45M · -35.10%
Net Income: $-3,065,848 · 51.79%
EPS: $-0.02 · 51.93%
Op Income: $-2,709,735
FCF YoY: -43.76%

Performance & Tape

52W High: $0.02
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: -0.36
Avg Volume: 1.12K

Get TickerSpark's AI analysis on THCBF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime